GILEAD SCIENCES INC (GIS.DE) Fundamental Analysis & Valuation

FRA:GIS • US3755581036

Current stock price

119.68 EUR
-1.48 (-1.22%)
Last:

This GIS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. GIS.DE Profitability Analysis

1.1 Basic Checks

  • GIS had positive earnings in the past year.
  • In the past year GIS had a positive cash flow from operations.
  • In the past 5 years GIS has always been profitable.
  • GIS had a positive operating cash flow in each of the past 5 years.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • GIS has a Return On Assets of 14.42%. This is amongst the best in the industry. GIS outperforms 91.14% of its industry peers.
  • With an excellent Return On Equity value of 37.49%, GIS belongs to the best of the industry, outperforming 96.20% of the companies in the same industry.
  • GIS's Return On Invested Capital of 19.49% is amongst the best of the industry. GIS outperforms 97.47% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GIS is significantly above the industry average of 11.35%.
  • The last Return On Invested Capital (19.49%) for GIS is above the 3 year average (17.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GIS has a better Profit Margin (28.90%) than 88.61% of its industry peers.
  • In the last couple of years the Profit Margin of GIS has grown nicely.
  • GIS has a Operating Margin of 39.98%. This is amongst the best in the industry. GIS outperforms 93.67% of its industry peers.
  • GIS's Operating Margin has been stable in the last couple of years.
  • GIS has a better Gross Margin (78.83%) than 67.09% of its industry peers.
  • GIS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. GIS.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GIS is creating value.
  • Compared to 1 year ago, GIS has less shares outstanding
  • GIS has less shares outstanding than it did 5 years ago.
  • GIS has a better debt/assets ratio than last year.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.52 indicates that GIS is not in any danger for bankruptcy at the moment.
  • GIS has a Altman-Z score of 4.52. This is in the better half of the industry: GIS outperforms 68.35% of its industry peers.
  • The Debt to FCF ratio of GIS is 2.64, which is a good value as it means it would take GIS, 2.64 years of fcf income to pay off all of its debts.
  • GIS has a Debt to FCF ratio of 2.64. This is amongst the best in the industry. GIS outperforms 87.34% of its industry peers.
  • GIS has a Debt/Equity ratio of 0.97. This is a neutral value indicating GIS is somewhat dependend on debt financing.
  • GIS has a Debt to Equity ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.52
ROIC/WACC2.2
WACC8.84%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that GIS should not have too much problems paying its short term obligations.
  • GIS has a worse Current ratio (1.55) than 62.03% of its industry peers.
  • GIS has a Quick Ratio of 1.40. This is a normal value and indicates that GIS is financially healthy and should not expect problems in meeting its short term obligations.
  • GIS has a Quick ratio of 1.40. This is comparable to the rest of the industry: GIS outperforms 40.51% of its industry peers.
  • GIS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. GIS.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • GIS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
  • GIS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.40%.
  • GIS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.58% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
  • Based on estimates for the next years, GIS will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue Next Year3.43%
Revenue Next 2Y4.69%
Revenue Next 3Y4.88%
Revenue Next 5Y5.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

6

4. GIS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.17, which indicates a rather expensive current valuation of GIS.
  • GIS's Price/Earnings ratio is rather cheap when compared to the industry. GIS is cheaper than 87.34% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.78, GIS is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 15.82, GIS is valued correctly.
  • Based on the Price/Forward Earnings ratio, GIS is valued cheaply inside the industry as 91.14% of the companies are valued more expensively.
  • GIS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 17.17
Fwd PE 15.82
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GIS is valued cheaper than 87.34% of the companies in the same industry.
  • 91.14% of the companies in the same industry are more expensive than GIS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.36
EV/EBITDA 13.07
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of GIS may justify a higher PE ratio.
PEG (NY)2.03
PEG (5Y)6.08
EPS Next 2Y9.79%
EPS Next 3Y9.45%

6

5. GIS.DE Dividend Analysis

5.1 Amount

  • GIS has a Yearly Dividend Yield of 2.44%.
  • Compared to an average industry Dividend Yield of 0.63, GIS pays a better dividend. On top of this GIS pays more dividend than 94.94% of the companies listed in the same industry.
  • GIS's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years7
Div Non Decr Years7
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 47.04% of the earnings are spent on dividend by GIS. This is a bit on the high side, but may be sustainable.
  • GIS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP47.04%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

GIS.DE Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

FRA:GIS (4/10/2026, 7:00:00 PM)

119.68

-1.48 (-1.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-23
Inst Owners92.51%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap148.57B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.54
Price Target134.83 (12.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend2.79
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)0%
PT rev (3m)15.48%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)-6.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.32%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-1.92%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE 17.17
Fwd PE 15.82
P/S 5.9
P/FCF 18.36
P/OCF 17.33
P/B 7.65
P/tB N/A
EV/EBITDA 13.07
EPS(TTM)6.97
EY5.82%
EPS(NY)7.56
Fwd EY6.32%
FCF(TTM)6.52
FCFY5.45%
OCF(TTM)6.91
OCFY5.77%
SpS20.3
BVpS15.65
TBVpS-1.79
PEG (NY)2.03
PEG (5Y)6.08
Graham Number49.54
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.52
F-Score8
WACC8.84%
ROIC/WACC2.2
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.43%
Revenue Next 2Y4.69%
Revenue Next 3Y4.88%
Revenue Next 5Y5.49%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y10.85%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GIS.DE Fundamental Analysis FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 7 / 10 to GIS.DE.


What is the valuation status for GIS stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for GIS stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GIS.DE) is 17.17 and the Price/Book (PB) ratio is 7.65.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 8.46% in the next year.